APA (7th ed.) Citation

T, Q., M, A., K, A. A., A, G., A, N., O, H., . . . M, R. (2025). Biologics and Oral Small Molecules Are Not Associated With Increased Major Adverse Cardiovascular Events or Venous Thromboembolism in Inflammatory Bowel Disease. Inflammatory bowel diseases, 31(7), 1910. https://doi.org/10.1093/ibd/izae267

Chicago Style (17th ed.) Citation

T, Qapaja, Abu-Rumaileh M, Alsabbagh Alchirazi K, Gharaibeh A, Naser A, Hamid O, Alayan D, and Regueiro M. "Biologics and Oral Small Molecules Are Not Associated With Increased Major Adverse Cardiovascular Events or Venous Thromboembolism in Inflammatory Bowel Disease." Inflammatory Bowel Diseases 31, no. 7 (2025): 1910. https://doi.org/10.1093/ibd/izae267.

MLA (9th ed.) Citation

T, Qapaja, et al. "Biologics and Oral Small Molecules Are Not Associated With Increased Major Adverse Cardiovascular Events or Venous Thromboembolism in Inflammatory Bowel Disease." Inflammatory Bowel Diseases, vol. 31, no. 7, 2025, p. 1910, https://doi.org/10.1093/ibd/izae267.